TKTL1 and non-small cell lung carcinoma: Although TKTL1 is overexpressed in non-small cell lung cancer, it is unrelated to patient outcomes in terms of OS, disease-free survival, or tumor node metastasis stages.[38] In this study, TKTL1 is a protective factor in IPF.